This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
While the drop in drug overdose deaths is promising, and could potentially be pa...
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...
Welcome back to Endpoints Weekly! This week was another busy one in DC, with two...
Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes ...
Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes ...
More generic drug prices decreased than increased in January, a new report from ...
The FDA on Thursday approved Neurotech Pharmaceuticals’ cell therapy for an eye ...
Bayer is asking shareholders to authorize a potential equity offer that would al...
Bluebird bio went from a high-flying $10 billion company in 2018 during the heyd...
President Donald Trump's nominees for NIH director and FDA commissioner sailed t...
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depr...
[Sponsored] MedCity News Editor in Chief Arundhati Parmar moderated a webinar wi...
This week, Healthcare IT Today is attending HIMSS25 in Las Vegas! For those not ...
When some former MyoKardia execs reunited with $300 million for a new "heart hea...
Nimbus Therapeutics is getting a new CEO after more than six years, as Jeb Keipe...
GEM HEALTH’s Series A round was co-led by HealthTrend Capital and LFE Capital an...